New Zealand
   
Include All CSL Sites

Vivotif® Oral

Oral, live, attenuated Typhoid vaccine.

What is Vivotif® Oral? 
  • Vivotif® Oral is an oral, live, attenuated typhoid vaccine for active immunization against typhoid, in adults and children above 6 years of age.
  • Vivotif® Oral is a vaccine used to prevent typhoid fever. Typhoid fever is a severe form of infection caused by a type of Salmonella bacteria. Vaccination with Vivotif® Oral is recommended for adults and children over 6 years of age who live in or travel through areas where typhoid fever occurs.

How it works
  • Vivotif® Oral contains live bacteria called Salmonella typhi strain Ty21a, which do not cause typhoid fever.
  • Vivotif® Oral works by causing the body to produce its own protection against the bacteria (germs) which cause typhoid fever. The body makes substances called antibodies, which destroy the Salmonella typhi bacteria. If you have been vaccinated against Salmonella typhi, your body is able to attack the bacteria if you come in contact with it.
  • Protection with Vivotif® Oral requires a full course of 3 doses. After a full course most people will product enough antibodies to prevent typhoid fever. However, as with all vaccines, 100% protection cannot be guaranteed.

How much to take
Take one capsule of Vivotif® Oral every second day, that is
Day 1 - 1 capsule,
Day 3 - 1 capsule,
Day 5 - 1 capsule,
until all 3 capsules have been taken.

When to take it
Take Vivotif® Oral on an empty stomach, 1 hour before food. Food can interfere with the absorption of Vivotif® Oral.

Vivotif® capsules must be stored in the fridge (between 2ºC and 8ºC).

 

VIVOTIF® Oral Typhoid vaccine

VIVOTIF is an unfunded prescription medicine. Normal doctor’s fees and pharmacy charges will apply.

VIVOTIF is used to prevent typhoid fever caused by a type of Salmonella bacteria. Each VIVOTIF capsule contains no less than 2 x 109 live Salmonella typhi strain Ty21a bacteria. VIVOTIF has benefits and risks. Do not use VIVOTIF if you have lowered immunity due to illness (including HIV/AIDS or cancer), or due to treatment with medicines such as corticosteroids, cyclosporin or treatment for cancer (including radiation therapy); an illness, with fever; bowel infection or an allergy to VIVOTIF components. Avoid food 1 hour after vaccination. Tell your doctor about allergies to other medicines or other substances, such as foods, preservatives or dyes; vaccination in the last 4 weeks; current and past medical conditions; current or planned pregnancy; breast-feeding; other medicines including those for which you needed no prescription.As with any medicine some side effects may occur. Tell your doctor or pharmacist if you notice any of the following: high temperature; headache; itchy rash; eating and drinking less than usual, loss of appetite; nausea or vomiting; constipation; diarrhoea; stomach cramps or pain; joint pain or aching muscles; tiredness or weakness. Tell your doctor immediately or go to the nearest accident and emergency if you notice skin rash, itchiness, or other severe skin reactions; raised, itchy swellings on the skin; swelling of the face, lips, mouth, throat or neck which may cause difficulty in swallowing or breathing. Tell your doctor or pharmacist if you have any unpleasant effects or do not feel well after having VIVOTIF. Ask your Doctor if Vivotif is right for you. Use strictly as directed. For further information, consult your doctor. Additional consumer medicine information(dated July 2015) is available at www.medsafe.govt.nz or from Seqirus, Auckland. Freephone 0800 502 757 or www.seqirus.co.nz.VIVOTIF is a registered trademark of PaxVax Berna GmbH, Switzerland.

VIVO-017-02/17 TAPS MR5131

Helpful Links 

Consumer Medicine Information 
Medicine Data Sheet

Last Updated: 26-02-2017
© 2017 Seqirus